David Allison

Director at Arpeggio Biosciences.

Raised on Arpeggio Biosciences filings

$24.1M

of $39.9M offered across 2 Form D filings

Form D filings: 2
Teammates: 7
Last filing: Nov 24, 2025

Company

Arpeggio Biosciences

Biotech · Boulder, CO

Transcriptomics and machine learning for drug discovery

Transcriptomics and machine learning for drug discovery

Investors: 14
Still open: $15.8M

Investors: 14
Sector: Biotech
HQ: Boulder, CO

Arpeggio Biosciences filings

Arpeggio Biosciences Form D filings
Filed	Security	Sold of offered	Filing
Nov 24, 2025	Equity	$20M/ $35.3M	Form D
Mar 27, 2025	Equity	$4M/ $4.6M	Form D

EquityFiled Nov 24, 2025Form D
$20M/ $35.3M
EquityFiled Mar 27, 2025Form D
$4M/ $4.6M

Works with

Also named on Arpeggio Biosciences filings

Joseph G. AzofeifaPresident and CEO, Form D signerForm D signer Laura NorrisExecutive Officer Timothy ReadExecutive Officer Aaron RoystonDirector Mira ChaurushiyaDirector Samuel KintzDirector Amit MehtaDirector